Prime Capital Investment Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
17,897
-1,662
| -8% | -$201K | 0.03% | 317 |
|
|
2025
Q1 | $2.18M | Buy |
19,559
+1,144
| +6% | +$128K | 0.03% | 349 |
|
|
2024
Q4 | $1.79M | Sell |
18,415
-444
| -2% | -$43.2K | 0.03% | 324 |
|
|
2024
Q3 | $2.17M | Sell |
18,859
-1,180
| -6% | -$136K | 0.03% | 300 |
|
|
2024
Q2 | $2.13M | Sell |
20,039
-1,369
| -6% | -$146K | 0.03% | 303 |
|
|
2024
Q1 | $2.07M | Buy |
21,408
+1,157
| +6% | +$112K | 0.03% | 337 |
|
|
2023
Q4 | $2.04M | Buy |
20,251
+15,927
| +368% | +$1.61M | 0.03% | 319 |
|
|
2023
Q3 | $440K | Buy |
4,324
+288
| +7% | +$29.3K | 0.01% | 492 |
|
|
2023
Q2 | $407K | Buy |
4,036
+1,387
| +52% | +$140K | 0.01% | 522 |
|
|
2023
Q1 | $244K | Sell |
2,649
-481
| -15% | -$44.3K | 0.01% | 470 |
|
|
2022
Q4 | $284K | Buy |
+3,130
| New | +$284K | 0.01% | 434 |
|
|
2019
Q4 | – | Sell |
-230
| Closed | -$20K | – | 631 |
|
|
2019
Q3 | $20K | Sell |
230
-306
| -57% | -$26.6K | ﹤0.01% | 418 |
|
|
2019
Q2 | $49K | Buy |
+536
| New | +$49K | 0.01% | 246 |
|
|
2018
Q1 | – | Sell |
-38
| Closed | -$3K | – | 266 |
|
|
2017
Q4 | $3K | Buy |
+38
| New | +$3K | ﹤0.01% | 227 |
|